Navigation Links
Study Makes Strides in Understanding Ovarian Cancer
Date:4/26/2010

Findings may lead to development of screening tests for early detection

MONDAY, April 26 (HealthDay News) -- New understanding about the early stages of ovarian cancer may lead to the development of a new screening test for the cancer, U.S. researchers say.

In the study, scientists uncovered early tumors and precancerous lesions in inclusion cysts, which fold into the ovary from its surface.

"This is the first study giving very strong evidence that a substantial number of ovarian cancers arise in inclusion cysts and that there is indeed a precursor lesion that you can see, put your hands on, and give a name to," lead author Jeff Boyd, chief scientific officer at Fox Chase Cancer Center in Philadelphia, said in a news release. "Ovarian cancer most of the time seems to arise in simple inclusion cysts of the ovary, as opposed to the surface epithelium."

Boyd and his colleagues analyzed ovaries removed from women with BRCA gene mutations (who have a 40 percent lifetime risk of developing ovarian cancer) and from women with no known genetic risk factors for ovarian cancer.

In both groups of women, gene expression patterns in the cells of inclusion cysts were dramatically different than normal ovarian surface cells. For example, the cells of inclusion cysts had increased expression of genes that control cell division and chromosome movement. The researchers also found that cells from very early tumors and tumor precursor lesions frequently had extra chromosomes.

"Previous studies only looked at this at the morphologic level, looking at a piece of tissue under a microscope," Boyd said. "We did that but we also dissected away cells from normal ovaries and early-stage cancers, and did genetic analyses. We showed that you could follow progression from normal cells to the precursor lesion, which we call dysplasia, to the actual cancer, and see them adjacent to one another within an inclusion cyst."

With these findings, researchers can try to develop new screening tests to detect ovarian cancer in the earliest stages, when it is still treatable. Ovarian cancer kills nearly 15,000 women in the United States each year. Fewer than half of ovarian cancer patients live more than five years after diagnosis.

The study was published April 26 in the journal PLoS One.

More information

The American Cancer Society has more about ovarian cancer.



-- Robert Preidt



SOURCE: Fox Chase Cancer Center, news release, April 26, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Brown Rice Tied to Better Heart Health in Study
2. NIH study confirms location of stem cells near cartilage-rich regions in bones
3. Immune cells predict success of head and neck cancer treatment, U-M study finds
4. Noncardiac Chest Pain May Warrant More Management: Study
5. SGIC Study Finds Drivers Are Losing Their Cool At School
6. Health impacts of mobile phone use to be explored in huge new study
7. Study of Williams syndrome patients reveals specific genes role in intelligence
8. Study Finds Patients Breathe Easier After Weight-Loss Surgery
9. Knowledge is power in Penn State blood pressure study
10. Breast density change linked to cancer development in WHI hormone replacement study
11. Ovarian cancer study offers vital clues for new therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented ... the lowdown on sciatica in a new episode of "Success Files," which is ... events and innovation and investigates each subject in-depth with passion and integrity. , ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: